These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2144745)

  • 1. CA-15.3, TPA and MCA as markers for breast cancer.
    Barak M; Steiner M; Finkel B; Abrahamson J; Antal S; Gruener N
    Eur J Cancer; 1990; 26(5):577-80. PubMed ID: 2144745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of CA 15-3, mucin-like carcinoma-associated antigen, tumor polypeptide antigen, and carcinoembryonic antigen in monitoring early breast cancer patients.
    Pectasides D; Pavlidis N; Gogou L; Antoniou F; Nicolaides C; Tsikalakis D
    Am J Clin Oncol; 1996 Oct; 19(5):459-64. PubMed ID: 8823487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is tissue polypeptide antigen still a useful tumor marker in breast carcinoma? Comparison with CA15.3 and MCA.
    Gion M; Mione R; Gatti C; Dittadi R; Leon A; Nascimben O; Pizzorno B; Bruscagnin G
    Tumori; 1990 Aug; 76(4):360-4. PubMed ID: 2399565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from a prospective study.
    Eskelinen M; Hippeläinen M; Kettunen J; Salmela E; Penttilä I; Alhava E
    Anticancer Res; 1994; 14(2B):699-703. PubMed ID: 8010729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of mucinous-like carcinoma associated antigen (MCA) in breast pathology: comparison with carcinoembryonic antigen (CEA) and tissue polypeptide antigen (TPA).
    Saccani Jotti G; Fontanesi M; Colombo A; Valtolina M; Tardini A
    Int J Biol Markers; 1990; 5(3):145-52. PubMed ID: 2286779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucin-like cancer-associated antigen (MCA) compared with CA 15-3 in advanced breast cancer.
    Steger GG; Mader R; Derfler K; Moser K; Dittrich C
    Klin Wochenschr; 1989 Aug; 67(16):813-7. PubMed ID: 2796251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
    Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
    BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of a mucin-like carcinoma-associated antigen in monitoring breast cancer patients in comparison with CA 15-3.
    Miserez AR; Günes I; Müller-Brand J; Walther E; Fridrich R; Mäcke H
    Eur J Cancer; 1991; 27(2):126-31. PubMed ID: 1827273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of CA-549 with CA 15-3 and MCA in patients with metastatic breast cancer.
    de Wit R; Hoek FJ; Bakker PJ; Veenhof CH
    Ann Oncol; 1992 Apr; 3(4):314-5. PubMed ID: 1390307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment concentrations of breast carcinoma antigen (CA 15.3) and mucin-like carcinoma-associated antigen in patients with carcinoma of the breast.
    Góźdź SS; Kowalska MM; Słuszniak JT; Słuszniak A; Korejba W; Bukowski J; Banasińska E; al-Jazzaf H; Szymendera JJ
    Tumour Biol; 1989; 10(2):103-8. PubMed ID: 2734547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.
    Nicolini A; Colombini C; Luciani L; Carpi A; Giuliani L
    Br J Cancer; 1991 Jul; 64(1):154-8. PubMed ID: 1854615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal cancer follow-up: the effectiveness of sequential CEA, TPA and Ca 19-9 evaluation in the early diagnosis of recurrences.
    Barillari P; Sammartino P; Cardi M; Ricci M; Gozzo P; Cesareo S; Cerasi A
    Aust N Z J Surg; 1991 Sep; 61(9):675-80. PubMed ID: 1877936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of tumour markers TAG 12 with CA 15-3 and MCA in breast cancer diagnosis.
    Eskelinen M; Hippelainen M; Salmela E; Paajanen H; Carlsson L; Jonsson P; Alhava E
    Anticancer Res; 1992; 12(1):39-42. PubMed ID: 1567179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human tissue polypeptide antigen in breast cancer.
    Nemoto T; Constantine R; Chu TM
    J Natl Cancer Inst; 1979 Dec; 63(6):1347-50. PubMed ID: 292806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of mucinous-like cancer antigen (MCA) in women with breast disease: preliminary results.
    Valenti G; Zanardi S; Valtolina M; Bombardieri E; Boccardo F
    Cancer Detect Prev; 1991; 15(4):285-9. PubMed ID: 1794135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of MCA, CA 15-3, CEA and CA-125 for discrimination between metastatic breast cancer and adenocarcinoma of other primary sites.
    De Wit R; Hoek FJ; Bakker PJ; Veenhof CH
    J Intern Med; 1991 May; 229(5):463-6. PubMed ID: 2040873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of a new tumour marker TAG 12 in breast cancer.
    Eskelinen M; Hippeläinen M; Carlsson L; Jonsson P
    Anticancer Res; 1991; 11(2):805-8. PubMed ID: 2064336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up of metastatic breast cancer patients with a mucin-like carcinoma-associated antigen: comparison to CA 15.3 and carcinoembryonic antigen.
    Bieglmayer C; Szepesi T; Neunteufel W
    Cancer Lett; 1988 Nov; 42(3):199-206. PubMed ID: 2461250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis.
    Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Kiviranta A; Hallman K; Holm L; Weiner E; Tamsen L
    Gynecol Oncol; 1990 Oct; 39(1):16-25. PubMed ID: 2227569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancer.
    Rasoul-Rockenschaub S; Zielinski CC; Kubista E; Vavra N; Pospischil E; Staffen A; Czerwenka K; Aiginger P; Spona J
    Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1067-72. PubMed ID: 2759162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.